Comments
Lilly extends grip on U.S. rights to Cymbalta
07.07.2012. | (Reuters) - Eli Lilly & Co said on Friday that it gained six more months of U.S. exclusivity on its Cymbalta antidepressant for conducting pediatric studies, extending Lilly's hold on the $4 billion-a-year drug until December 2013....
